Another study reported significantly elevated in vitro kinase activity of LRRK2 in PBMCs from LRRK2 G2019S mutation carriers in comparison to non-carriers, while the pS935-LRRK2 level was increased in sPD compared to controls (Melachroinou et al., 2020). The gene discussed is LRRK2; the disease is Platelet storage pool disease.